Viewing nowCombinationShurras Tablets
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.

MFDS item code 200308867 · Notified 2003.02.04
This product's status changed to Approval withdrawn on 2024.04.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.); prevention of Mendelson syndrome
This medication is used for the treatment of gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, gastroesophageal reflux disease, post-operative ulcers, and ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). It is also administered to prevent Mendelson's syndrome prior to anesthesia. This drug helps protect the gastric mucosa by regulating gastric acid secretion and alleviating symptoms of inflammation and ulcers. Therefore, it is effectively used for various gastrointestinal-related diseases.
Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by administration of nonsteroidal anti-inflammatory drugs or for concomitant use to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by administration of nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. Reflux esophagitis For 8 weeks, take 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. Preanesthetic medication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This drug should not be used in patients undergoing dialysis or those with a history of acute porphyria. It is also advisable not to administer this medication to patients with impaired kidney function, those who have undergone upper gastrointestinal surgery, pregnant or possibly pregnant women, and to premature infants or newborns. Patients on a potassium-restricted diet should avoid using this medication. Patients with liver function issues, a history of drug allergies, the elderly, and those with past kidney disorders should use this medication with caution. If taking non-steroidal anti-inflammatory drugs, extra care is advised as this drug may hide symptoms of gastric cancer, so patients with gastric ulcers or new or changed dyspeptic symptoms over the age of 40 should confirm they do not have malignant diseases before use. Those with Helicobacter pylori-positive gastric and duodenal ulcers should undergo eradication therapy. Caution should also be exercised when used in severely ill patients in intensive care units or those with hypophosphatemia or difficulty swallowing. While taking this medication, rare allergic reactions, blood abnormalities, liver function impairment, cardiac arrhythmias, gastrointestinal symptoms, neurological symptoms, myalgia, skin rashes, etc., may occur, and if any abnormal symptoms are present, consult a doctor immediately. It is important not to take this medication for a long time and to use the minimum effective dose while closely monitoring the treatment progress. Elderly patients or those with chronic lung diseases, diabetes, or weak immune systems may have an increased risk of pneumonia, so caution is necessary. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other medications, so if you are taking other drugs, be sure to inform your healthcare provider, especially when using medications that affect blood coagulation, as frequent blood tests may be required. It is advisable not to use this drug during pregnancy or breastfeeding, and its safety in children has not been established, so it is preferable to avoid use in this population. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, so visit a hospital immediately. Finally, this medication reduces gastric acid secretion and may promote bacterial growth in the stomach; therefore, regular examinations, including eye examinations, are necessary when used for long periods.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a sealed container to prevent air or moisture from entering, and keep it at a temperature ranging between 1 to 30 degrees Celsius at room temperature. Storing it this way helps maintain the effectiveness of the medication for a long time.
[Domestic] Green round film-coated tablets [Export] Orange round film-coated tablets
30 tablets per bottle, 500 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride · Tripotassium Bismuth Dicitrate +1 more
Prescription medication · Combination
Hankook Hyutex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.